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Abstract 
 The emergence and resurgence of arboviruses in recent history is challenging our 
scientific understanding of mosquito-borne diseases and their transmission. To better 
contextualize recent epidemics and gain insight into historical trends in arbovirus incidence,  
we conducted a literature review to identify serosurveys from Africa and Asia. We compiled all 
serosurvey data into a table and tested for variation in disease incidence across countries and 
between age categories. Our analysis showed that disease incidence was consistently higher in 
the >15 age category than the <15 age category and revealed significant variation in incidence 
across countries. In addition, the mean incidence of yellow fever virus was substantially higher 
than the incidences of the other diseases included in the analysis. Higher incidence in the >15 
age category is likely due to the long-term persistence of antibodies in human sera, while a 
higher incidence of yellow fever can likely be attributed to widespread vaccine use. 
Characteristics of countries with high disease incidence included a tropical climate, extended 
rainy season, and flat terrain, and countries with low disease incidence occurred at higher 
elevations and/or reflected a desert climate. This analysis can hopefully reveal the conditions 
most important in facilitating an arbovirus outbreak, leading to targeted prevention strategies in 
high-risk areas. It also highlights the need for continued serosurveys as a method of documenting 
disease spread. 
Introduction 
 Throughout history, the incidence of diseases and patterns of disease spread have proven 
to be highly variable and unpredictable (Petersen, 2012; Claflin and Webb, 2015). The 
complexity of pathogen emergence and persistence is exemplified by arboviruses, which are 
viruses that rely on arthropods for transmission between hosts (Gubler, 2001). The inter-
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dependent relationship between the components required for arbovirus transmission (virus, 
vector, host)—coupled with external factors that affect the interactions between the 
components—make it difficult to predict and control the spread of arboviruses (Kuno and Chang, 
2005). In recent history, the emergence and resurgence of certain arboviruses has posed 
significant public health problems in many countries. Examples of resurgent diseases include 
dengue virus and yellow fever virus, which were historically prominent but thought to be 
controlled by the mid-20th century. In the case of yellow fever, this included the introduction and 
widespread use of a licensed vaccine. However, the incidence of these diseases in the past 30 
years has increased dramatically, resulting in their spread to previously unaffected regions of the 
world and afflicting a greater number of people (Gubler, 1998). Emergent diseases such as Zika 
virus and chikungunya virus reflect a different pattern of incidence, as they were first 
characterized in the 1950s but remained relatively dormant until the onset of large-scale 
epidemics in the early-21st century. Like the resurgent diseases, the geographic ranges of Zika 
and chikungunya viruses have also expanded because of recent epidemics (Powers, 2009). 
 The recent trend of arbovirus emergence and resurgence is perplexing, because diseases 
such as Zika virus and chikungunya virus have been observed in humans for decades but haven’t 
caused widespread epidemics until recently. These epidemics have been noticed by public health 
authorities, as they have occurred in historically non-endemic areas. Similarly, dengue virus and 
yellow fever virus were thought to be controlled, yet have also been responsible for recent 
epidemics. Prior to these epidemics, Zika, chikungunya, dengue, and yellow fever viruses were 
thought to be of relatively low public health concern. This raises the question of which factors or 
changes have enabled these diseases to emerge or resurge at the same point in time, and thus 
warrant further exploration into the potential underlying causes of recent epidemics. Factors 
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theorized to be responsible for the trend of arbovirus emergence and resurgence include viral 
recombination and mutation, urbanization, increased commerce, global population growth, and 
climate change, but no causal relationships have been made between these factors and disease 
spread (Dash et al., 2013). Understanding the patterns underlying the spread of arboviruses is 
crucial in identifying which factors may have contributed to the trend of recent arbovirus 
epidemics. 
When considering the impact of diseases on human populations, it is important to 
understand their history, basic biology/virology, and public health implications. Zika virus is a 
Flavivirus closely related to Dengue, West Nile, and Yellow Fever viruses. First characterized in 
humans in 1954, Zika virus remained of low public health concern for decades (Alera et al., 
2015). However, a notable outbreak of Zika virus occurred in Yap Island, Micronesia in 2007, 
with an estimated infection rate of 73% among the island’s 7391 inhabitants (Weaver et al., 
2016). Subsequent epidemics have led to the spread of Zika virus throughout Africa, Asia, 
Oceania, and the Americas, having been detected in Brazil in 2015 (Kindhauser et al., 2016). 
Transmitted by Aedes mosquitoes, Zika virus has multiple animal reservoirs, including 
nonhuman primates and other wild and domestic animals (Plourde and Bloch, 2016). 
Transmission occurs when a mosquito injects the virus into the skin of a mammalian host. Zika 
virus is a positive-sense, single-stranded genomic RNA which codes for three structural and 
seven nonstructural proteins. The interaction of the viral envelope protein with cell surface 
receptors mediates the initial entry of the virus into multiple types of skin cells. Once infected, 
the formation of autophagosomes within a cell can enhance viral replication, which occurs in the 
cellular cytoplasm (Hamel et al., 2015). 
Historical Patterns of Arboviral Seroprevalence across Africa and Asia 
 
4 
Dengue virus is another Flavivirus with a large global burden, as the virus is present in 
over 100 countries worldwide and causes an approximated 50 million infections per year. 
(Simmons et al., 2012). It is estimated that two-fifths of the world’s population is at risk for 
dengue infection, making dengue virus the most widespread vector-borne disease (Murrell et al., 
2011). Dengue virus is transmitted by Aedes mosquitoes and utilizes nonhuman primates as 
reservoirs. Like Zika virus, dengue virus consists of a positive-sense, single-stranded RNA 
genome which encodes three structural and seven nonstructural proteins. The envelope 
glycoprotein initiates interactions with cell surface receptors, which facilitates the entry of the 
virus into cells. An incubation period of 4-7 days occurs post-infection, characterized by viral 
replication in the dendritic cells closest to the bite site. During this period, macrophages and 
lymphocytes can also be infected with the virus, which ultimately enters the blood stream. There 
are four serotypes of dengue virus, each of which is antigenically distinct and can result in 
conditions such as dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. No 
effective treatment or vaccine has been discovered for the dengue serotypes, contributing to an 
inability to control the spread of the disease (Murrell et al., 2011). 
Yellow fever virus is a Flavivirus endemic to regions of Africa and South America. From 
the 18th to the 20th century, yellow fever virus posed a significant threat to human health, but the 
deployment of two licensed, effective vaccines in the 1930s and 1940s caused disease incidence 
to decline. In recent years, the disease has been making a resurgence in certain regions of the 
world, often becoming endemic in areas without effective immunization programs (Monath and 
Vasconcelos, 2015). Currently, yellow fever virus is responsible for over 30,000 deaths annually 
(Quaresma et al., 2013). The virus contains a positive-sense, single-stranded RNA genome and is 
transmitted between nonhuman primates, mosquitoes, and humans (Monath and Vasconcelos, 
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2015). Following infection by a mosquito, the virus initially replicates in local lymph nodes, but 
spreads to organs such as the liver, heart, and kidneys, where it can cause the formation of 
lesions. The liver is the primary target of yellow fever virus, and infection can result in the 
apoptosis of liver cells (Quaresma et al., 2013). 
Chikungunya virus is an Alphavirus that was discovered in Tanzania in 1952. The virus 
has since spread throughout the world, reaching India, Asia, the Pacific, and the Americas and 
causing numerous epidemics (Sudeep and Parashar, 2008). Between 2004 and 2007, large-scale 
epidemics of chikungunya virus occurred in Kenya, the Indian Ocean, and the Indian 
Subcontinent, and over one and a half million cases were thought to have occurred in India alone 
during this time. On Reunion Island in the southwest Indian Ocean, an estimated 266,00 cases of 
chikungunya occurred in 2005, representing 34% of the island’s population (Presti et al., 2014). 
Chikungunya is a mosquito-transmitted virus that utilizes nonhuman primates as intermediates in 
its transmission cycle. The virus is a single-stranded, positive-sense RNA genome that encodes 
four nonstructural proteins and three structural proteins. Chikungunya virus enters cells via 
endocytosis, following the binding of envelope glycoproteins to cell surface receptors (Weaver 
and Lecuit, 2015). Once in the skin, the virus infects susceptible cells such as macrophages and 
fibroblasts and then enters the blood stream, where it can spread to the liver, muscle joints, 
lymphoid tissue, and the brain (Presti et al., 2015). 
 The recent trend of large-scale arbovirus epidemics due to the emergence and resurgence 
of diseases poses a significant public health challenge in many countries. To better understand 
this trend, one approach is to analyze data describing the historical incidence of diseases. 
Historical data pertaining to disease incidence is useful because it can reveal trends in disease 
spread. We therefore attempt to better understand and contextualize recent arbovirus outbreaks 
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by looking at historical patterns of disease incidence in endemic countries. Two key questions 
raised by this analysis are whether the incidence of diseases varies by age and geographic 
location. To test for the presence of this variation, we will perform three different analyses. First, 
we will test for variation in incidence across countries, for each disease individually. Second, we 
will again test for variation in incidence within countries, but for each disease and age category. 
Third, we will test for variation in incidence by age category, for each disease and across all 
countries. We anticipate variability in disease incidence across countries due to climatic and 
geographic differences, but don’t expect major differences in disease incidence across age 
groups, because the incidence data comes from historically endemic countries. 
Methods 
 To compile a dataset of historical arbovirus incidence, arbovirus serosurveys were first 
identified through a literature review. Using Google Scholar, searches were conducted with the 
following word combinations: “arbovirus, sero, human,” “dengue, sero, human,” “chikungunya, 
sero, human,” “Zika, sero, human,” “arbovirus, antibody, human,” “dengue, antibody, human,” 
“chikungunya, antibody, human,” “Zika, antibody, human,” “arbovirus, molecular, human,” 
“dengue, molecular, human,” “chikungunya, molecular, human,” and “Zika, molecular, human.” 
Each search excluded “West Nile Virus” and was designated to include “Africa” or “Asia.” The 
general search criteria were thus serosurveys conducted in Africa and Asia within the last 75 
years, and empirical incidence data as opposed to systematic reviews. A maximum of 1,000 
results were returned for each search, ordered by citation count and search relevance. All 
titles/abstracts were scanned to determine if a serosurvey had been conducted, and a PDF was 
located and saved for each article containing primary incidence data. For the purpose of this 
study, serosurveys conducted among febrile or clinically-suspected patients were excluded, to 
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prevent the inclusion of biased incidence data. The data from all serosurveys identified by the 
literature review was manually compiled into a data table for further analysis. The table 
contained the following column headings: “Country,” “Sub-region,” “Disease,” “Incidence,” 
“Sample Size,” “Age Group,” “Age Category (<15 or >15),” “Test Type,” and “Citation.” 
Sample size refers to the total number of individuals tested for the presence of a particular 
disease, while incidence refers to the number of individuals who tested positive for the disease. 
The results of some serosurveys were not reported by age group, so age data was recorded where 
appropriate. 
All statistical analyses were conducted in RStudio (1.0.44). Disease, age category, and 
country were utilized as covariates. First, to observe trends in disease incidence across countries, 
the observed incidence of a single disease was computed for all countries individually. To 
accomplish this, all row entries for a disease (i.e. Zika) were selected for, and a new data frame 
was created containing solely these entries. The total number of positive samples was then 
summed for each country and divided by the total sample size. For countries that lacked 
incidence data pertaining to the selected disease, all NA’s were replaced with zeros. A matrix 
was then created with a row number equal to the total number of countries and the following 
column headings: “Country,” “Positive,” “Total,” “Mean,” “Upper,” “Lower.” Country names 
were added to the matrix (“Country”), as were the total number of positive samples for a country 
(“Positive”) and the total number of samples tested (“Total”). Using the “binom” package (1.1-1; 
Dorai-Raj, 2014), a 95% credible interval of the mean incidence was calculated for each country, 
using Bayesian inference. The software infers a posterior distribution of incidences and we used 
the default parameters, which are a beta prior distribution and a binomial likelihood (see Gelman 
et al., 1997 for more information). The upper and lower limits of each credible interval were 
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added to the matrix under their corresponding columns, as well as the mean incidence. This 
analysis was repeated for each of the four diseases. 
To observe trends in disease incidence between countries and age categories, the 
incidence rates of a single disease were computed for both age categories individually (<15 and 
>15) and across all countries. All row entries for a disease were first selected for, and the 
resulting data frame was modified to select all entries pertaining to one of the age categories. A 
95% credible interval of the mean incidence was then computed for each country, reflecting the 
incidence of a single disease in one of the age categories. For example, a 95% credible interval 
was computed for Zika virus in all countries individually, for the <15 age category. There were 
two age categories for four total diseases. 
 To observe trends in disease incidence between age categories, the incidence of each 
disease was computed for each age category. Instead of initially selecting for a disease, an age 
category was selected for. The number of positive samples and total sample size were then 
summed for each disease within the age category. The matrix containing the credible intervals 
and associated data was modified to include a column titled “Disease,” replacing the column 
titled “Country.” A total of two tables were created, and both tables contained the incidence of 
all four diseases within an age category. To produce figures, the R packages “maps” (3.1.1; 
Brownrigg, 2016) and “ggplot2” (Wickham, 2009) were used. 
Results 
Disease by Country 
 Zika virus ranged from a low incidence of 0.0083 (9.18x10^-6 to 0.0215, 95% CrI) in 
Egypt to a high incidence of 0.8651 (0.7802 to 0.9432, 95% CrI) in Gambia. The mean incidence 
of Zika virus across all countries was 0.2401. Burkina Faso and Gambia reflected an incidence 
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greater than 0.5, while in China, Egypt, Ethiopia, Mozambique, Pakistan, Uganda, and Zambia, 
the incidence of Zika virus was less than 0.1. Gambia was the only country whose credible 
interval of the mean incidence did not overlap with the credible interval of another country. The 
interval of Gambia was notably higher than the intervals of other countries, as the upper limit of 
the next-highest credible interval was 0.5551, observed in Burkina Faso (0.5102 to 0.5551, 95% 
CrI). Ethiopia displayed a particularly low credible interval, as the upper limit was only 0.0185 
(0.0005 to 0.0185, 95% CrI; see Fig. 1; Fig. 2). 
 Dengue virus ranged from a low incidence of 0.0015 (1.56x10^-6 to 0.0038, 95% CrI) in 
Saudi Arabia to a high incidence of 0.6351 (0.6061 to 0.6640, 95% CrI) in Sri Lanka. The mean 
incidence of dengue virus across all countries was 0.2378. Philippines, Sri Lanka, and Thailand 
reflected an incidence greater than 0.5, while in Egypt, Japan, Madagascar, Niger, Saudi Arabia, 
Senegal, South Africa, and Sudan the incidence of dengue virus was less than 0.1. Sri Lanka was 
the only country whose entire credible interval was above 0.6, although the interval still 
overlapped with that of Thailand. Unlike Zika virus, overlap occurred between all credible 
intervals, and no interval was entirely distinct. The intervals of South Africa and Saudi Arabia 
were notably lower than the rest, as the upper limits were 0.0036 (0.0003 to 0.0037, 95% CrI) 
and 0.0038, respectively (see Fig. 3; Fig. 4). 
 Chikungunya virus ranged from a low incidence of 0.0048 (0 to 0.0183, 95% CrI) in 
Palau to a high incidence of 0.7351 (0.7152 to 0.7549, 95% CrI) in Burkina Faso. The mean 
incidence of chikungunya virus across all countries was 0.2438. Burkina Faso, Guinea, Tanzania, 
and Vietnam reflected an incidence greater than 0.5, while in China, Ethiopia, India, Namibia, 
Niger, Pakistan, Palau, Solomon Islands, South Africa, and Vanuatu the incidence of 
chikungunya virus was less than 0.1. The entire credible interval of Burkina Faso was greater 
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than 0.7, but it still overlapped with the interval of Tanzania, which had the highest upper limit 
of any interval at 0.8231 (0.6294 to 0.8231, 95% CrI). Overlap was observed between all 
intervals. Countries in Africa showed a sharp contrast in incidence; Burkina Faso and Tanzania 
reflected incidence values greater than 0.7, while Ethiopia and Namibia had incidence values less 
than 0.02 (0.0116 and 0.0079, respectively). Palau, Solomon Islands, and Vanuatu, all island 
nations in the Pacific Ocean, reflected particularly low incidence values of chikungunya virus, as 
the highest incidence among the three was 0.0104 (0 to 0.0398, 95% CrI) in Vanuatu (see Fig. 5; 
Fig. 6). 
 Yellow fever virus ranged from a low incidence of 0.0035 (0 to 0.0136, 95% CrI) in 
Egypt to a high incidence of 0.7520 (0.7325 to 0.7713, 95% CrI) in Burkina Faso. The mean 
incidence of yellow fever virus across all countries was 0.3093. Burkina Faso, Central African 
Republic, Cote D’Ivoire, Lebanon, Sudan, and Thailand reflected an incidence greater than 0.5, 
while in Egypt, Niger, Somalia, Tanzania, and Uganda the incidence of yellow fever virus was 
less than 0.1. Burkina Faso was the only country whose credible interval of the mean incidence 
did not overlap with the credible interval of another country. The credible interval of Lebanon 
exceeded 0.7, with an upper limit of 0.7037 (0.5279 to 0.7037, 95% CrI). Egypt and Somalia 
displayed notably low credible intervals, as the upper limits were 0.0136 and 0.0215 (0 to 
0.0215, 95% CrI), respectively (see Fig. 7; Fig. 8). 
  Comparing the incidence of multiple diseases within a country also yielded interesting 
results. Burkina Faso reflected a concurrently high incidence of multiple diseases, as Zika virus 
had an incidence of 0.5327 (0.5102 to 0.5551, 95% CrI), chikungunya virus an incidence of 
0.7351 (0.7152 to 0.7549, 95% CrI), and yellow fever virus an incidence of 0.7520 (0.7325 to 
0.7713, 95% CrI). Thailand followed a similar pattern, as dengue virus and yellow fever virus 
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had incidence values of 0.6151 (0.5997 to 0.6305, 95% CrI) and 0.5891 (0.4934 to 0.6839, 95% 
CrI). In contrast, Egypt reflected a concurrently low incidence of multiple diseases, as the 
incidences of Zika, dengue, and yellow fever viruses were 0.0083 (9.18x10^-6 to 0.0215, 95% 
CrI), 0.0521 (0.0209 to 0.0867, 95% CrI), and 0.0035 (0 to 0.0136, 95% CrI), respectively. 
Ethiopia and Niger also demonstrated this pattern of multiple low incidences. Other countries 
reflected a mixed pattern of incidences, such as in Tanzania where the incidence of chikungunya 
virus was relatively high at 0.7278 (0.6294 to 0.8231, 95% CrI), but Zika and yellow fever 
viruses had much lower incidence values of 0.1757 (0.0635 to 0.2980, 95% CrI) and 0.0739 
(0.0300 to 0.1222, 95% CrI), respectively. Philippines also demonstrated this pattern, with a 
relatively high incidence of dengue virus in comparison to relatively low incidences of Zika virus 
and chikungunya virus. 
Disease by Country and Age Category 
 In the <15 age category, Zika virus ranged from a low incidence of 0.0062 (0 to 0.0236, 
95% CrI) in Egypt to a high incidence of 0.4449 (0.4116 to 0.4783, 95% CrI) in Senegal.  
The mean incidence of Zika virus in the <15 age category was 0.1511. In the >15 age category, 
Zika virus ranged from a low incidence of 0.0149 (1.7x10^-4 to 0.0384, 95% CrI) in Egypt to a 
high incidence of 0.9082 (0.8274 to 0.9785, 95% CIr) in Gambia. The mean incidence of Zika 
virus in the >15 age category was 0.3171. The largest difference in incidence between age 
categories was 0.4915 in Gambia, and the smallest difference in incidence was 0.0051 in India. 
In seven of thirteen countries containing incidence data for both age categories, no overlap was 
observed in the 95% credible intervals of Zika virus incidence between age categories. In all 
seven cases, the credible interval of the >15 age category was higher than that of the <15 age 
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category. A difference in incidence of greater than 0.2 was observed between age categories in 
Ivory Coast, Nigeria, and Senegal.  
 In the <15 age category, dengue virus ranged from a low incidence of 0.0155 (0.0055 to 
0.0266, 95% CrI) in Niger to a high incidence of 0.6291 (0.5997 to 0.6583, 95% CrI) in Sri 
Lanka. The mean incidence of dengue virus in the <15 age category was 0.1948. In the >15 age 
category, dengue virus ranged from a low incidence of 0.0015 (1.56x10^-6 to 0.0038, 95% CrI) 
in Saudi Arabia to a high incidence of 0.9356 (0.9252 to 0.9459, 95% CrI) in Thailand. The 
mean incidence of dengue virus in the >15 age category was 0.3609. The largest difference in 
incidence between age categories was 0.7613 in Thailand, and the smallest difference in 
incidence was 0.0497 in Kuwait. In thirteen of fifteen countries containing incidence data for 
both age categories, no overlap was observed in the 95% credible intervals of dengue virus 
incidence between age categories. In these cases, the credible interval of the >15 age category 
was higher than that of the <15 age category in all but two cases. For Indonesia and Laos, the 
credible interval of incidence in the >15 age category was lower than that of the <15 age 
category. A difference in incidence of greater than 0.2 was observed between age categories in 
Cameroon, Indonesia, Singapore, Taiwan, and Thailand. 
 In the <15 age category, chikungunya virus ranged from a low incidence of 0.0113 
(0.0031 to 0.0209, 95% CrI) in Niger to a high incidence of 0.6786 (0.4428 to 0.9006, 95% CrI) 
in Tanzania. The mean incidence of chikungunya virus in the <15 age category was 0.2370. In 
the >15 age category, chikungunya virus ranged from a low incidence of 0.0764 (0.0219 to 
0.1380, 95% CrI) in China to a high incidence of 0.9323 (0.8816 to 0.9775, 95% CrI) in Senegal. 
The mean incidence of chikungunya virus in the >15 age category was 0.3695. The largest 
difference in incidence between age categories was 0.4576 in Nigeria, and the smallest 
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difference in incidence was 0.0386 in India. In thirteen of eighteen countries containing 
incidence data for both age categories, no overlap was observed in the 95% credible intervals of 
chikungunya virus incidence between age categories. In all thirteen cases, the credible interval of 
the >15 age category was higher than that of the <15 age category. A difference in incidence of 
greater than 0.2 was observed between age categories in Ivory Coast, Kenya, Mozambique, 
Niger, Nigeria, Senegal, and Taiwan. 
 In the <15 age category, yellow fever virus ranged from a low incidence of 0.0078 (0 to 
0.0299, 95% CrI) in Egypt to a high incidence of 0.5629 (0.5322 to 0.5936, 95% CrI) in Senegal. 
The mean incidence of yellow fever virus in the <15 age category was 0.1793. In the >15 age 
category, yellow fever virus ranged from a low incidence of 0.0064 (0 to 0.0246, 95% CrI) in 
Egypt to a high incidence of 0.8788 (0.8447 to 0.9118, 95% CrI) in Senegal. The mean incidence 
of yellow fever virus in the >15 age category was 0.3922. The largest difference in incidence 
between age categories was 0.5571 in Niger, and the smallest difference in incidence was 0.0014 
in Egypt. In nine of thirteen countries containing incidence data for both age categories, no 
overlap was observed in the 95% credible intervals of yellow fever virus between age categories. 
In all nine cases, the credible interval of the >15 age category was higher than that of the <15 age 
category. A difference in incidence of greater than 0.2 was observed between age categories in 
Ivory Coast, Niger, and Senegal. 
Age Category by Disease 
  Overall, the mean incidence of each disease was higher in the >15 age category than in 
the <15 age category (see Fig. 9). The largest difference in the incidence of a disease between 
age categories was reflected by yellow fever virus, which had an incidence of 0.3619 (0.3530 to 
0.3708, 95% CrI) in the >15 category and an incidence of 0.1928 (0.1842 to 0.2014, 95% CrI) in 
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the <15 category. The smallest difference occurred for dengue virus, which had incidences of 
0.3699 (0.3621 to 0.3777, 95% CrI) and 0.3174 (0.3067 to 0.3281, 95% CrI) in the >15 and <15 
age categories, respectively. In addition, none of the credible intervals for the mean incidence of 
a disease overlapped between the age categories. For example, the credible interval of the mean 
incidence of Zika virus in the <15 age category was 0.1172 to 0.1328, compared to a higher 
interval of 0.2390 to 0.2573 in the >15 age category. This was true for all four diseases. 
 Within each category, the order of disease incidences varied slightly. For the <15 age 
category, dengue virus displayed an incidence of 0.3174 (0.3067 to 0.3281, 95% CrI), which was 
the highest incidence out of the four diseases. Chikungunya virus had the second highest 
incidence of 0.2571 (0.2483 to 0.2659, 95% CrI), followed by yellow fever virus at 0.1928 
(0.1842 to 0.2014, 95% CrI) and Zika virus at 0.1250 (0.1172 to 0.1328, 95% CrI). There was no 
overlap in credible intervals within the <15 age category. For the >15 age category, dengue virus 
also had the highest incidence at 0.3699 (0.3621 to 0.3777, 95% CrI), but was followed by 
yellow fever virus at 0.3619 (0.3530 to 0.3708, 95% CrI), chikungunya virus at 0.3188 (0.3124 
to 0.3253, 95% CrI) and Zika virus at 0.2481 (0.2390 to 0.2573, 95% CrI), which had the lowest 
incidence in both age categories. Within the >15 age category, the credible intervals for dengue 
virus and yellow fever virus displayed significant overlap.  
Discussion 
 In this study, we investigated the historical incidence of arboviruses in endemic countries 
throughout Africa and Asia. We focused the analysis on four arboviruses that have caused some 
of the most recent global epidemics: Zika virus, dengue virus, chikungunya virus, and yellow 
fever virus. After compiling a dataset of disease incidence from serosurveys, we analyzed the 
dataset in three ways: disease by country, disease by age category and country, and age category 
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by disease. The first section of the analysis revealed significant variation in disease incidence 
between countries. In addition, the mean incidence of yellow fever virus across all countries was 
substantially higher than the incidences of the other three diseases, which displayed relatively 
similar values. In the second section of the analysis, the incidence of a disease within a country 
was always lower for the <15 age category than the >15 age category, except for the incidence of 
dengue virus in Indonesia and Laos, which reflected a higher incidence of dengue virus in the 
<15 age category than the >15 age category. The third section of the analysis showed that the 
incidences of all four diseases were higher in the >15 age category than the <15 age category. 
This result is not surprising, and tells us that the sample sizes of Laos and Indonesia were much 
smaller than the sample size of all the countries. Our findings partially supported our initial 
hypothesis, where we anticipated variability in disease incidence across countries due to climatic 
and geographic differences, but didn’t expect major differences in disease incidence across age 
groups because the incidence data comes from historically endemic countries. While disease 
incidence varied greatly across countries, it also varied between age groups, suggesting that age 
may be an important determinant of infection. 
 The mean incidence of yellow fever virus across all countries was higher than the mean 
incidences of the other three diseases. Because vaccinated individuals can show up as 
seropositive for yellow fever (Poland et al., 1981), one possible explanation for this observation 
is the availability and use of a vaccine against the disease. Between 1933 and 1961, mass yellow 
fever vaccination campaigns were carried out in African countries such as Burkina Faso, 
Cameroon, and Ivory Coast (WHO, 2017). After vaccination with the live, attenuated virus, an 
immune response is triggered which results in the production of antibodies against the virus. 
Yellow fever antibodies have been shown to persist in human sera for 30-35 years post-
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vaccination, and may even confer lifelong immunity (Poland et al., 1981). The serum from a 
person who received the yellow fever vaccine would therefore test positive for yellow fever virus 
antibodies by standard diagnostic tests (such as antibody neutralization), even if they were never 
infected with the virus by a mosquito. These mass vaccination campaigns, which continue to 
distribute about 20-60 million vaccines annually, may explain why yellow fever virus appears to 
have a higher incidence than the other diseases (Monath and Vasconcelos, 2015). However, the 
interruption of mass vaccination campaigns in Africa between the 1960s and 1990s may have 
also assisted in the evolution of current epidemics and the resurgence of the disease (WHO, 
2016). 
 The incidences of all four diseases were observed to be higher in the >15 age category 
than in the <15 age category, with two exceptions. This trend may be explained by the 
persistence of antibodies to a disease in human sera for many years after initial infection. For 
example, antibodies to dengue virus have been detected in the sera of infected individuals more 
than 60 years after initial infection with the disease (Imrie et al., 2007). Similarly, antibodies to 
chikungunya virus have been detected in human sera 20 years post-infection, including 
consistently high titers of antibodies in a large percentage of sera (Nitatpattana, 2014). The long-
term persistence of antibodies can explain why disease incidence appears higher in the >15 age 
category, as the probability of obtaining a positive diagnostic test increases with age. While this 
trend was reflected by a vast majority of the dataset, there were two exceptions: the incidence of 
dengue virus in Indonesia and Laos was higher in the <15 age category than in the >15 age 
category. In the case of Indonesia, a 1995 serosurvey indicated a high incidence of dengue 
antibodies in children under 15 years of age (Graham et al., 1999). This was likely due to the 
occurrence of a recent outbreak, and a study published in 1987 reported that dengue had recently 
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become endemic to many large cities and small towns throughout Indonesia. The incidence of 
dengue virus had increased dramatically since the initial recognition of the disease in Indonesia 
in 1968, and had spread to 26 of 27 provinces by 1985 (Sumarmo, 1987). The recent spread of 
dengue virus in relation to the serosurvey analysis could explain why the disease displayed a 
higher incidence among the <15 age category. A similar situation was observed in the case of 
Laos, as a 2015 serosurvey also reflected a high incidence of dengue in the <15 age category 
(Conlan et al., 2015). In 2010 and 2013, Laos experienced widespread epidemics of dengue 
virus, reflecting a trend of increasing emergence. During these epidemics, the largest number of 
cases occurred among 10- to 20-year-olds, and children accounted for the majority of deaths 
(Khampapongpane et al., 2014). This provides a plausible explanation for the elevated incidence 
of dengue observed in the <15 age category. 
 Multiple diseases were observed to have high incidences in countries such as Burkina 
Faso and Thailand and low incidences in countries such as Egypt, Ethiopia, and Niger. Many 
factors and conditions may contribute to these patterns of high or low incidences, including 
climate and geography. Burkina Faso has a tropical climate characterized by warm, dry winters 
and hot, wet summers. Most of the country is a relatively flat, landlocked savanna that occurs at 
low elevation (CIA, 2017). Thailand also has a tropical climate, with both a rainy, warm 
monsoon season and a dry, cool monsoon season. While Thailand contains both plateaus and 
mountains, most of the country is a flat, central plain located in a river valley (CIA, 2017). 
Similarities between Burkina Faso and Thailand, which have high disease incidences, include a 
tropical climate containing a rainy season, and flat terrain (i.e. savannas or plains) which occurs 
at low elevations. In contrast, countries with low disease incidences display notable differences 
in both climate and geography when compared to countries like Burkina Faso and Thailand.  
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Egypt is a vast desert plateau with an arid desert climate characterized by hot, dry summers and 
moderate winters (CIA, 2017). Niger is composed of predominantly desert plains and sand 
dunes, with a desert climate that is hot, dry, and dusty (CIA, 2017). Ethiopia has a tropical 
monsoon climate, but the terrain consists of a high plateau with a central mountain range (World 
Factbook, 2017). Shared characteristics of countries with low disease incidences include a desert 
climate and the presence of plateaus which occur at higher elevations. In the case of Ethiopia, the 
high elevation together with plateaus may even mitigate the effects of a tropical climate on 
disease incidence, due to a lack of vector survival. Aedes mosquitoes cannot establish and 
proliferate at higher elevations, thus inhibiting the spread of vector-borne diseases such as 
arboviruses and leading to lower incidence rates (Eisen and Moore, 2013). As evidenced by this 
analysis, climatic and geographic conditions can vary greatly within regions of the world, and 
this may affect the incidence of diseases. For example, Niger and Burkina Faso are neighboring 
countries, yet display striking differences in climate and geography which may provide an 
explanation for the sharp contrast in disease incidences between the countries. Within countries, 
multiple factors can affect the spread and prevalence of diseases, and determining precisely what 
these conditions are will be essential in predicting and preventing the next major epidemic. 
 One major limitation of this study involves the cross-reactivity of human antibodies to 
multiple diseases. Our observation that the incidences of dengue, chikungunya, and Zika viruses 
fall within a narrow range could be explained by similarities in vector, but could also be 
accounted for by known issues of antibody cross-reactivity in serosurveys. For example, 
antibodies to dengue virus have been shown to consistently bind and neutralize Zika virus, and 
vice versa. This is due to the high degree of similarity between Flaviviruses such as dengue virus 
and Zika virus, in terms of sequence and structural homology (Priyamvada et al., 2016). A high 
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rate of cross-reactivity has also been detected between yellow fever virus and dengue virus, as 
pre-existing yellow fever virus antibodies have been shown to neutralize dengue virus (Allwinn 
et al., 2002). While cross-reactivity between chikungunya virus (an Alphavirus) and Flaviviruses 
is low, it can still occur (Cho et al., 2008). Disease cross-reactivity can potentially explain the 
observed similarity between disease incidence values, as a person infected with dengue virus 
may also test positive for Zika virus and yellow fever virus, despite not being infected with these 
diseases. In addition to cross-reactivity, serosurvey data does not indicate when infection with a 
disease occurred. Limitations in the methodology of this study also had to be taken into 
consideration in the analysis. Due to a finite number of published serosurveys, small sample 
sizes were obtained for some countries, and samples were only taken from certain regions within 
countries. The search terms used in the literature review were also unable to identify every 
published serosurvey. While these obstacles were acknowledged, they were unavoidable and did 
not affect the outcomes of the study. 
 This analysis will hopefully add to the understanding of emerging and resurging arboviral 
diseases and highlight the need for continued serosurveys. Serosurveys are an important tool for 
documenting the spread of disease and lend insight into historical patterns of disease incidence. 
Expansion of this dataset will be necessary to broaden the reach of this study, in terms of 
increasing sample sizes and including more countries in the analysis. Inclusion of South 
American countries would be another interesting option to consider, as arbovirus epidemics in 
South America are a more recent phenomenon. Dengue virus first emerged in South America in 
the 1990s, while chikungunya virus emerged in 2013 and Zika virus in 2015 (Fauci and Morens, 
2016; Zanluca et al., 2015). Given the recent nature of these epidemics, we would expect to see 
trends in serosurvey data like those of dengue virus in Indonesia and Laos, with higher disease 
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incidence in the <15 age category than the >15 age category. Most importantly, discovering 
trends in disease incidence and determinants of disease spread may enable increased preparation 
for epidemics. This analysis can potentially reveal what conditions are most important in 
facilitating arbovirus epidemics, and thus serve as a predictor for where the next major outbreak 
may occur. Investing in increased prevention and preparation is an important priority, but 
targeted strategies must be developed to minimize associated costs. Using this analysis as a 
predictor can help determine the high-risk areas where these strategies should be employed, with 
an ultimate goal of reducing the public health impact of arboviruses and saving human lives. 
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Figure 1: Barplot of mean seropositivity of Zika virus in 51 countries; the absence of a 
bar for a country indicates a lack of data. 
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Figure 3: Barplot of mean seropositivity of dengue virus in 51 countries; the absence 
of a bar for a country indicates a lack of data. 
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Figure 5: Barplot of mean seropositivity of chikungunya virus in 51 countries; the 
absence of a bar for a country indicates a lack of data. 
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Figure 7: Barplot of mean seropositivity of yellow fever virus in 51 countries; the 
absence of a bar for a country indicates a lack of data. 
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Figure 9: Barplot of mean seropositivity of four diseases by age category; red bars 
correspond to the >15 age category and gray bars correspond to the <15 age category. 
